Denis O’Shaughnessy

466 total citations
11 papers, 339 citations indexed

About

Denis O’Shaughnessy is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Denis O’Shaughnessy has authored 11 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Denis O’Shaughnessy's work include Retinal Diseases and Treatments (8 papers), Retinal Imaging and Analysis (6 papers) and Retinal Development and Disorders (5 papers). Denis O’Shaughnessy is often cited by papers focused on Retinal Diseases and Treatments (8 papers), Retinal Imaging and Analysis (6 papers) and Retinal Development and Disorders (5 papers). Denis O’Shaughnessy collaborates with scholars based in United States, United Kingdom and Belgium. Denis O’Shaughnessy's co-authors include Julia M. Polak, Mohammad A. Ghatei, Ying C. Lee, Gian‐Luca Ferri, Stephen R. Bloom, A.M.J. Buchan, Jason S. Slakter, Thomas E. Adrian, Lesley Probert and Timothy L. Jackson and has published in prestigious journals such as Gastroenterology, Neurology and Ophthalmology.

In The Last Decade

Denis O’Shaughnessy

11 papers receiving 329 citations

Peers

Denis O’Shaughnessy
Si Hyung Lee South Korea
C Giusti Italy
Jidi Fu China
Ahmara G. Ross United States
Lawrence Gnanaraj United Kingdom
Rachel Gillespie United Kingdom
Si Hyung Lee South Korea
Denis O’Shaughnessy
Citations per year, relative to Denis O’Shaughnessy Denis O’Shaughnessy (= 1×) peers Si Hyung Lee

Countries citing papers authored by Denis O’Shaughnessy

Since Specialization
Citations

This map shows the geographic impact of Denis O’Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis O’Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis O’Shaughnessy more than expected).

Fields of papers citing papers by Denis O’Shaughnessy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis O’Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis O’Shaughnessy. The network helps show where Denis O’Shaughnessy may publish in the future.

Co-authorship network of co-authors of Denis O’Shaughnessy

This figure shows the co-authorship network connecting the top 25 collaborators of Denis O’Shaughnessy. A scholar is included among the top collaborators of Denis O’Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis O’Shaughnessy. Denis O’Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Moster, Mark L., Raymond S. Douglas, Kimberly Cockerham, et al.. (2023). Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) (P3-9.001). Neurology. 100(17_supplement_2). 3 indexed citations
3.
Vignal, Catherine, Jean‐François Girmens, Isabelle Audo, et al.. (2021). Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. BioDrugs. 35(2). 201–214. 31 indexed citations
4.
Cohen, Michael N., Denis O’Shaughnessy, Kate Fisher, et al.. (2020). APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration. British Journal of Ophthalmology. 105(5). 716–722. 21 indexed citations
5.
Freiberg, Florentina J., Stephan Michels, Alyson Muldrew, et al.. (2018). Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial. British Journal of Ophthalmology. 103(4). 469–474. 8 indexed citations
6.
Jackson, Timothy L., David S. Boyer, David M. Brown, et al.. (2017). Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology. 135(7). 761–761. 34 indexed citations
7.
Jackson, Timothy L., Usha Chakravarthy, Jason S. Slakter, et al.. (2014). Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 122(1). 138–145. 29 indexed citations
8.
Introini, Ugo, Giuseppe Casalino, Giacinto Triolo, et al.. (2014). Stereotactic Radiotherapy for Polypoidal Choroidal Vasculopathy: A Pilot Study. Ophthalmologica. 233(2). 82–88. 6 indexed citations
9.
Jackson, Timothy L., Ronald P. Danis, Mauro Goldbaum, et al.. (2013). RETINAL VASCULAR ABNORMALITIES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 34(3). 568–575. 17 indexed citations
10.
Jackson, Timothy L., Usha Chakravarthy, Peter K. Kaiser, et al.. (2013). Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration. Ophthalmology. 120(9). 1893–1900. 49 indexed citations
11.
Ferri, Gian‐Luca, Thomas E. Adrian, Mohammad A. Ghatei, et al.. (1983). Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology. 84(4). 777–786. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026